Avoid common mistakes on your manuscript.
Retraction Note: European Journal of Clinical Microbiology & Infectious Diseases (2020) 40:407–411
The Editor-in-Chief has retracted this article. Concerns about the methodology were raised in a Letter to the Editor [1] and the authors responded [2]. Upon further assessment of the Letter and the authors' response, the Editor-in-Chief no longer has confidence in the veracity of the conclusions. In particular, although this was a clinical trial, there was a lack of an appropriate control group. In addition, consent for participation in this study was waived. However, the Editor-in-Chief does not consider a waiver to be appropriate for a study of this nature.
Author Ferhat Arslan agrees with this retraction. Authors Yasemin Cag, Sacit Icten, Hasan Kocoglu, Sinan Uzman and Mahmut Tayyar Kalcioglu disagree with this retraction. The other authors have not responded to correspondence regarding this retraction.
References
Cakir B (2021) A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort. Eur J Clin Microbiol Infect Dis 40(3):663–664
Cag Y, Vahaboglu H (2021) A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort—authors’ reply. Eur J Clin Microbiol Infect Dis 40(6):1351–1352
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Cag, Y., Icten, S., Isik-Goren, B. et al. Retraction Note: A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort. Eur J Clin Microbiol Infect Dis 43, 401 (2024). https://doi.org/10.1007/s10096-023-04727-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-023-04727-1